KomturKomtur_Logo.svg
Contact

Practical Access Strategy for Real‑World Launch

Market access starts long before launch. Our Market Access Consulting helps pharma and biotech build strategies that are as practical as they are ambitious.

We connect clinical intent with the realities of distribution, reimbursement, and adoption. Our work brings pricing and regulatory insights together with channel planning and launch design.

Whether entering an untested market, planning a phased rollout, or building a value case, we chart a clear path from development to delivery. Our guidance is grounded in real operations, so strategy moves to practical execution without friction.

We shape access and market entry by clarifying import and regulatory frameworks, stress testing supply routes, assessing pricing and reimbursement readiness, mapping stakeholders, as well as designing launch models and field infrastructure.

We turn access strategy into practical launch readiness so therapies reach patients faster and markets open without avoidable delays.

About Market Access Consulting

For teams that want clarity early, before decisions are locked in, our engagement is tailored, collaborative, and focused on turning strategy into tangible access results.

  • Access-Ready Strategy Development

    Plans that factor policy, pricing, logistics, timing, and market context, so access is achievable, not aspirational.

  • Execution-Focused Insight

    We focus on the details that matter. Importer of Record setup, distribution models, stakeholder engagement, and operational readiness.

  • Reimbursement Landscape Awareness

    Input on local pricing and reimbursement schemes, dossier submission, and early payer positioning.

  • Stakeholder Mapping & Coordination

    Identify and prepare the right networks across the value chain, from providers to payers to patient groups.

  • Embedded into Service Execution

    Because consulting is integrated with our access, distribution, and PSP delivery, recommendations gain immediate operational traction.

Our Market Access Consulting Services

Why Komtur?

  • One Platform, Integrated Access

    We orchestrate regulatory, operational, stakeholder, and medical functions to deliver Early Access, Compassionate Use, and Patient Support services in one patient-centric solution.

  • Lifecycle Continuity from Clinical to Commercial

    Our models support access from first patient supply through to commercialization. This enables agile launch sequencing and consistent patient continuity across stages.

  • Global Reach with Local Adaptation

    With 17 affiliates and deep regional expertise, we tailor implementation country by country. This helps ensure local realities don’t become global bottlenecks.

  • Trusted in Complex Access Environments

    Pharma, Biotech and rare disease innovators rely on Komtur to bridge stakeholder and patient needs with operational access, even when evidence is limited or infrastructure is fragmented.

  • Supporting the Full Patient Journey beyond Access

    Our Patient Support Programs deliver education, coordination, and care continuity. We help patients continue to benefit from therapy while reinforcing outcomes and long-term treatment success.

Start your market access plan

Discuss your access strategy with our experts and explore practical pathways to launch and patient access.

“We regularly see patient access become a missed opportunity when continuity and early access were not considered in the commercial launch plan.”

At Komtur, we believe that (access / launch planning ) should be built around lived patient experience and the realities of care provider.

Successfull integration of early patient access results in covering unmet needs and happy KOLs.